Connect with us

Hi, what are you looking for?


Pediatric Multicenter Study Shows Targeted Therapy for High-Risk…

A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s…

(PRWeb November 02, 2022)

Read the full story at


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like